Startups
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders.
Overview
Location
Germany, North Rhine-Westphalia, Langenfeld (Rheinland)
Employees
501-1000
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 24, 2023 | Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg | Belgium team to expand under Country Manager, Dr Pierre-Hervé Brun, providing CNS treatments to patients BRUSSELS and DÜSSELDORF, Germany, Jan. 24, 2023 /PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceu... |
| Dec 7, 2022 | Neuraxpharm expands into the Netherlands | The CNS specialist continues its strong expansion course in Europe and increases its presence from two to 20 countries in just six years NAARDEN, Netherlands and DÜSSELDORF, Germany, Dec. 7, 2022 /PRNewswire/ -- Neuraxpharm Group (Neuraxpha... |
| Nov 10, 2022 | Minoryx y Neuraxpharm se alían para ofrecer una nueva terapia a los pacientes con enfermedades raras del SNC en Europa | 09/11/2022 Nota de prensa MINORYX Y NEURAXPHARM SE ALÍAN PARA OFRECER UNA NUEVA TERAPIA A LOS PACIENTES CON ENFERMEDADES RARAS DEL SNC EN EUROPA Minoryx Therapeutics, compañía biotecnológica en fase avanzada especializada en el desarroll... |
| Jan 24, 2022 | Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France | DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ -- Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical cannabis produ... |
| Jan 24, 2022 | Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France | DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ -- Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical cannabis produ... |
| Oct 30, 2019 | German pharma company acquires Swiss cannabidiol startup |
Reviews 0
FAQ about Neuraxpharm
What has the press written about Neuraxpharm?
Parsers VC has collected 7 articles mentioning Neuraxpharm, among them “Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg” (Jan 24, 2023) and “Neuraxpharm expands into the Netherlands” (Dec 7, 2022).
Is Neuraxpharm still active?
Yes, Neuraxpharm is active; its latest activity on Parsers VC dates from Dec 19, 2025.